Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 1
2005 5
2006 1
2007 5
2008 5
2009 6
2010 2
2011 1
2012 3
2013 8
2014 6
2015 2
2016 6
2017 4
2018 12
2019 6
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Schuurhuis GJ, Heuser M, Freeman S, Béné MC, Buccisano F, Cloos J, Grimwade D, Haferlach T, Hills RK, Hourigan CS, Jorgensen JL, Kern W, Lacombe F, Maurillo L, Preudhomme C, van der Reijden BA, Thiede C, Venditti A, Vyas P, Wood BL, Walter RB, Döhner K, Roboz GJ, Ossenkoppele GJ. Schuurhuis GJ, et al. Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12. Blood. 2018. PMID: 29330221 Free PMC article. Review.
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Jongen-Lavrencic M, Grob T, Hanekamp D, Kavelaars FG, Al Hinai A, Zeilemaker A, Erpelinck-Verschueren CAJ, Gradowska PL, Meijer R, Cloos J, Biemond BJ, Graux C, van Marwijk Kooy M, Manz MG, Pabst T, Passweg JR, Havelange V, Ossenkoppele GJ, Sanders MA, Schuurhuis GJ, Löwenberg B, Valk PJM. Jongen-Lavrencic M, et al. Among authors: schuurhuis gj. N Engl J Med. 2018 Mar 29;378(13):1189-1199. doi: 10.1056/NEJMoa1716863. N Engl J Med. 2018. PMID: 29601269 Free article.
Can we incorporate MRD assessment into clinical practice in AML?
Ossenkoppele G, Schuurhuis GJ, van de Loosdrecht A, Cloos J. Ossenkoppele G, et al. Best Pract Res Clin Haematol. 2019 Jun;32(2):186-191. doi: 10.1016/j.beha.2019.05.003. Epub 2019 May 10. Best Pract Res Clin Haematol. 2019. PMID: 31204000 Review.
MRD in AML: does it already guide therapy decision-making?
Ossenkoppele G, Schuurhuis GJ. Ossenkoppele G, et al. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):356-365. doi: 10.1182/asheducation-2016.1.356. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913502 Free PMC article. Review.
MRD in AML: it is time to change the definition of remission.
Ossenkoppele GJ, Schuurhuis GJ. Ossenkoppele GJ, et al. Best Pract Res Clin Haematol. 2014 Sep-Dec;27(3-4):265-71. doi: 10.1016/j.beha.2014.10.008. Epub 2014 Oct 15. Best Pract Res Clin Haematol. 2014. PMID: 25455276 Review.
Cancer stem cell definitions and terminology: the devil is in the details.
Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, Roesch A, Schuurhuis GJ, Wöhrer S, Arock M, Zuber J, Cerny-Reiterer S, Johnsen HE, Andreeff M, Eaves C. Valent P, et al. Nat Rev Cancer. 2012 Nov;12(11):767-75. doi: 10.1038/nrc3368. Epub 2012 Oct 11. Nat Rev Cancer. 2012. PMID: 23051844 Review.
Towards cure of CML: why we need to know more about CML stem cells?
Janssen JJ, Schuurhuis GJ, Terwijn M, Ossenkoppele GJ. Janssen JJ, et al. Among authors: schuurhuis gj. Curr Stem Cell Res Ther. 2009 Sep;4(3):224-36. doi: 10.2174/157488809789057428. Curr Stem Cell Res Ther. 2009. PMID: 19492977 Review.
79 results